Abbott Laboratories

Abbott Laboratories

Yahoo Finance • 2 days ago

Microfluidic Device Systems - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $11.1 Billion by 2032 | Abbott, Danaher, Bio-Rad, and Siemens Healthineers Shape the Competition

Company Logo Target point-of-care diagnostics, precision medicine and drug discovery; automation, miniaturization and low reagent use can cut costs, speed workflows and support scalable growth Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "M... Full story

Yahoo Finance • 2 days ago

Is Abbott Laboratories (ABT) Undervalued On New Device And Test Launches?

Abbott Laboratories (ABT) has been back in focus after two health focused product milestones. The firm secured FDA and CE approvals for its UltiSynq defibrillation lead and launched the Panbio COVID-19/Flu A&B Self-Test in Canada. Despite... Full story

Yahoo Finance • 2 days ago

Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump

Approvals include compatibility with Abbott's FreeStyle Libre 3 Plus sensor and indications for type 2 diabetes and for pregnancy in type 1 diabetes. SAN DIEGO, November 12, 2026--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM)... Full story

Yahoo Finance • 3 days ago

Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts

Company Logo Capitalize on personalized medicine, advanced genetic testing and cancer diagnostics with tariff-aware sourcing, regional analysis and competitive insights. Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Molecular Cytogenetics -... Full story

Yahoo Finance • 4 days ago

Gene Amplification Technologies - Global Strategic Business Report: Capture $4.4B in New Revenue by 2030 as Abbott, Bio-Rad, bioMerieux, Cepheid and Becton Dickinson Battle for Share

Company Logo Target personalized medicine, diagnostics and pharma R&D with PCR, NGS and CRISPR innovation; tariff, regional and competitive insights reveal revenue opportunities. Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Gene Amplificat... Full story

Yahoo Finance • 5 days ago

New Abbott Panbio™ COVID-19/Flu A&B Self-Test Helps Canadian Families Make Informed Decisions During Respiratory Illness Season

New survey reveals 72 per cent of Canadians say knowing whether they had the flu or COVID-19 would help guide next stepsi Respiratory viruses often present with similar symptoms, making it difficult for families to know what steps to take... Full story

Yahoo Finance • 7 days ago

Does FDA Device Approval Change The Bull Case For Abbott (ABT)?

Abbott Laboratories reported a flurry of cardiology and oncology product updates over late October and early November 2026, including FDA approval for the Amplatzer Paraclose PVL Occluder, strong study results for the investigational Amule... Full story

Yahoo Finance • 8 days ago

National Advertising Division to Refer Kendal to Government Agencies and Advertising Platforms for Electing Not to Participate in Compliance Inquiry

BBB NATIONAL PROGRAMS Following a compliance inquiry stemming from a prior decision, BBB National Programs' National Advertising Division will refer Kendal Nutricare Limited to appropriate government and state agencies and advertising pla... Full story

Yahoo Finance • 8 days ago

Global Biohacking Wearable and Consumer Longevity Device Market Report 2026 | Capitalize on AI Biometrics as Apple, Samsung, Abbott, and Oura Drive Market to $45.03 Billion by 2030

Company Logo Apple, Samsung, Huawei, Abbott and ASUS. Profiled: competitors, regional shares, segments, trends and opportunities in biohacking wearables and longevity devices. Dublin, Nov. 06, 2026 (GLOBE NEWSWIRE) -- "Biohacking Wearabl... Full story

Yahoo Finance • 9 days ago

TC Energy reports strong third quarter 2026 operating and financial results

TC Energy Corporation Revising 2026 outlook higher and extending to a five-year outlook through to 2031 Announced approximately $3 billion of new growth projects CALGARY, Alberta, Nov. 05, 2026 (GLOBE NEWSWIRE) -- TC Energy Corporation... Full story

Yahoo Finance • 10 days ago

Abbott Laboratories (ABT) Posted Positive Trial Results For Two Heart Devices

Abbott Laboratories (NYSE:ABT) reported positive one year VERITAS trial outcomes for its Amulet 360 device in atrial fibrillation patients. The Amulet 360 Left Atrial Appendage Occluder showed high safety and efficacy for stroke risk reduc... Full story

Yahoo Finance • 10 days ago

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer

DALLAS & OSS, Netherlands, November 04, 2026--(BUSINESS WIRE)--Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulat... Full story

Yahoo Finance • 11 days ago

Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI Diagnostics

Company Logo Capitalize on demand for wearable, point-of-care biosensors driven by chronic disease monitoring, nanotechnology, personalized medicine, and food and environmental safety. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biosensor... Full story

Yahoo Finance • 11 days ago

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

BridgeBio Pharma, Inc. PALO ALTO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines... Full story

Yahoo Finance • 12 days ago

Should Retail Leadership Reset Require Action From Marzetti (MZTI) Investors?

Marzetti recently named Mark Christenson as President of its Retail business and promoted Rene Luichinger to Chief Customer Officer, assigning them responsibility for sales, marketing, innovation and customer strategy across its branded an... Full story

Yahoo Finance • 12 days ago

39 New Companies Join the 2026 Fortune Best Companies to Work For Southeast Asia List

Nearly two in five companies on this year's list are first-time entrants. DHL Group stays at No. 1. SINGAPORE, Nov. 3, 2026 /PRNewswire/ -- Fortune and Great Place To Work today named the 2026 Fortune Best Companies to Work For Southeast... Full story

Yahoo Finance • 12 days ago

Abbott Touts Favorable Outcomes In Cardiovascular Device Trials

Abbott Laboratories(NYSE:ABT) reported positive clinical trial results for two investigational cardiovascular devices at the Transcatheter Cardiovascular Therapeutics conference in San Diego, demonstrating high procedural success and low c... Full story

Yahoo Finance • 12 days ago

Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke

Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show the device achieved high closure rates of... Full story

Yahoo Finance • 12 days ago

HSS Medical Supply Announces Distributor Agreement for Abbott's ID NOW Rapid Molecular Testing Platform

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- One of the fastest-growing healthcare suppliers, HSS Medical Supply, announced a new vendor agreement with Abbott. The family-owned distribution company now includes Abbott's ID NOW™, a rapid molecula... Full story

Yahoo Finance • 12 days ago

Capital Power reports third quarter 2026 results

Capital Power Corporation EDMONTON, Alberta, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended September 30, 2026. Highlights Long-term Energy Supply Agreement... Full story